|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 31.01 USD | +3.26% |
|
+0.55% | -22.46% |
| 10-07 | VTv Therapeutics Gets FDA Orphan Drug Designation for HPPD in Sickle Cell Disease | DJ |
| 10-07 | VTv Therapeutics Gets FDA Orphan Drug Designation for Sickle Cell Candidate | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTVT | Delayed | |
CBOE
| VTVT | Real-time | |
|
Deutsche Boerse AG
| 5VT0 | Delayed | |
|
Tradegate
| 5VT0 | Real-time | |
|
Börse Stuttgart
| 5VT0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 33.47 | 40.45 | 41.17 |
| Spread/Res. | -7.35% | -23.34% | -24.68% |
| Spread/Supp. | +5.48% | +5.48% | +16.14% |
| Support | 29.4 | 29.4 | 26.7 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VTVT Stock
- Charts vTv Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
